GWAS and network analysis of co-occurring nicotine and alcohol dependence identifies significantly associated alleles and network
- PMID: 30488612
- PMCID: PMC6918694
- DOI: 10.1002/ajmg.b.32692
GWAS and network analysis of co-occurring nicotine and alcohol dependence identifies significantly associated alleles and network
Abstract
Alcohol dependence (AD) and nicotine dependence (ND) co-occur frequently (AD+ND). We integrated SNP-based, gene-based, and protein-protein interaction network analyses to identify shared risk genes or gene subnetworks for AD+ND in African Americans (AAs, N = 2,094) and European Americans (EAs, N = 1,207). The DSM-IV criterion counts for AD and ND were modeled as two dependent variables in a multivariate linear mixed model, and analyzed separately for the two populations. The most significant SNP was rs6579845 in EAs (p < 1.29 × 10-8 ) in GM2A, which encodes GM2 ganglioside activator, and is a cis-expression quantitative locus that affects GM2A expression in blood and brain tissues. However, this SNP was not replicated in our another small sample (N = 678). We identified a subnetwork of 24 genes that contributed to the AD+ND criterion counts. In the gene-set analysis for the subnetwork in an independent sample, the Study of Addiction: Genetics and Environment project (predominately EAs), these 24 genes as a set differed in AD+ND versus control subjects in EAs (p = .041). Functional enrichment analysis for this subnetwork revealed that the gene enrichment involved primarily nerve growth factor pathways, and cocaine and amphetamine addiction. In conclusion, we identified a genome-wide significant variant at GM2A and a gene subnetwork underlying the genetic trait of shared AD+ND. These results increase our understanding of the shared (pleiotropic) genetic risk that underlies AD+ND.
Keywords: alcohol dependence co-occurring nicotine dependence; genome-wide association studies; network analysis; pleiotropy.
© 2018 Wiley Periodicals, Inc.
Conflict of interest statement
Drs. Xiang, Yang, Zhou, and Gelernter declare no conflict of interest. Dr. Kranzler declares has been a consultant, advisory board member, or CME speaker for Indivior and Lundbeck. He is also a member of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative (ACTIVE), which in the last three years was supported by AbbVie, Alkermes, Amygdala Neurosciences, Arbor Pharmaceuticals, Ethypharm, Indivior, Lilly, Lundbeck, Otsuka, and Pfizer.
Figures
References
-
- Association AP (1994) Diagnostic and statistical manual of mental disorders. Forth edition. Washington, DC.
-
- Augustine RA, Seymour AJ, Campbell RE, Grattan DR, Brown CH (2018) Integrative neuro‐humoral regulation of oxytocin neuron activity in pregnancy and lactation. Journal of neuroendocrinology. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DA012690/DA/NIDA NIH HHS/United States
- R01 DA1843/MH/NIMH NIH HHS/United States
- R01 AA017535/NH/NIH HHS/United States
- VA Medical Research Service/International
- R01 AA11330/NH/NIH HHS/United States
- R01 AA011330/AA/NIAAA NIH HHS/United States
- R01 AA017535/AA/NIAAA NIH HHS/United States
- R01 DA12849/MH/NIMH NIH HHS/United States
- N01-HG-65403/NH/NIH HHS/United States
- P50 AA12870/NH/NIH HHS/United States
- RC2 DA028909/DA/NIDA NIH HHS/United States
- N01 HG065403/HG/NHGRI NIH HHS/United States
- K01 DA024758/DA/NIDA NIH HHS/United States
- R01 DA012849/DA/NIDA NIH HHS/United States
- RC2 DA028909/MH/NIMH NIH HHS/United States
- R01 DA018432/DA/NIDA NIH HHS/United States
- US Veterans Affairs Connecticut and Veterans Affairs Philadelphia Mental Illness Research, Education and Clinical Centers/International
- R01 DA12690/MH/NIMH NIH HHS/United States
- R01 DA18432/NH/NIH HHS/United States
- China Scholarship Council/International
- RC2 DA028909/NH/NIH HHS/United States
- P50 AA012870/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
